Induced pluripotent stem cell (iPSC) derived cell models offer an extraordinary opportunity to study human disease. We have developed a functional genomics screening platform to query biology within the context of these physiologically relevant cell types. We perturb genes at large scale utilising CRISPR knockout, CRISPR activation and CRISPR interference technologies. Our innovative approach is applicable across a wide range of biological questions and disease areas, including target ID.
Brain Implant Therapeutics (BIT) Pharma was founded in November 2015 by leaders from academia and industry. The company resides in Graz, Austria. BIT Pharma develops and commercializes technologies for site-specific drug delivery to the central nervous system (CNS), in particular the brain, exploiting tailored drug delivery systems.
BlueSky Immunotherapies, ein führendes Biotechnologieunternehmen in der klinischen Entwicklung, hat eine bahnbrechende virale Vektorplattform gegen Krebs entwickelt. Die Plattform namens delNS wurde entwickelt, um sowohl Interferon als auch Tumorantigene gleichzeitig zu produzieren. Dieser innovative Ansatz ist entscheidend, um die Immunabwehrmechanismen von Tumoren zu überwinden und sie effektiv zu bekämpfen.
Boehringer Ingelheim is working on breakthrough therapies that improve the lives of humans and animals. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. Around 52,000 employees serve more than 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.
CALYXHA develops novel small-molecule anti-inflammatory drugs
For more than 25 years, we have dedicated ourselves to developing, manufacturing and distributing hemostasis reagents. Our customers can always rely on us with scientific as well as practice-oriented issues. In cooperation with renowned international partners we constantly search for new paths.
Croma-Pharma GmbH, kurz Croma, ist ein international tätiges, pharmazeutisches Unternehmen mit Sitz in Leobendorf, Österreich. Seit über 40 Jahren werden innovative Arzneimittel und Medizinprodukte für die Bereiche Ophthalmologie, Orthopädie und ästhetische Dermatologie entwickelt, produziert und vertrieben. Damit leistet Croma seit vier Jahrzehnten wichtige Beiträge zur Verbesserung der Gesundheit und Lebensqualität.
Cutanos GmbH is a viennese biotech company founded in early 2021 focussing on preclinal development of antigen-specific vaccines and new treatments for autoimmune disorders. Cutanos uses a modular and highly flexible drug delivery system called the Langerhans Cell Targeted Delivery System (LC-TDS). With this technology, the company aims to realize innovative immunotherapies in conjunction with minimally invasive administration.